Growth Metrics

Armata Pharmaceuticals (ARMP) Operating Expenses: 2013-2024

Historic Operating Expenses for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to $47.6 million.

  • Armata Pharmaceuticals' Operating Expenses rose 17.15% to $2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was $17.2 million, marking a year-over-year increase of 5.72%. This contributed to the annual value of $47.6 million for FY2024, which is 4.82% up from last year.
  • According to the latest figures from FY2024, Armata Pharmaceuticals' Operating Expenses is $47.6 million, which was up 4.82% from $45.4 million recorded in FY2023.
  • Armata Pharmaceuticals' 5-year Operating Expenses high stood at $47.6 million for FY2024, and its period low was $22.4 million during FY2020.
  • Its 3-year average for Operating Expenses is $45.2 million, with a median of $45.4 million in 2023.
  • Data for Armata Pharmaceuticals' Operating Expenses shows a peak YoY soared of 50.04% (in 2022) over the last 5 years.
  • Armata Pharmaceuticals' Operating Expenses (Yearly) stood at $22.4 million in 2020, then rose by 26.27% to $28.3 million in 2021, then skyrocketed by 50.04% to $42.5 million in 2022, then rose by 6.98% to $45.4 million in 2023, then grew by 4.82% to $47.6 million in 2024.